| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $13.0M | -81.1% |
| SG&A Expense | $17.4M | -8.4% |
| Operating Income | -$8.6M | +90.2% |
| Pre-tax Income | -$7.9M | +91.0% |
| Income Tax | $348K | — |
| Net Income | -$8.2M | +90.6% |
| EPS (Basic) | -$0.26 | +90.9% |
| EPS (Diluted) | -$0.26 | +90.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.7M | -51.1% |
| Short-term Investments | $2.5M | +0.0% |
| Accounts Receivable | $5.0M | +175.0% |
| Current Assets | $28.2M | -45.2% |
| Total Assets | $28.4M | -48.9% |
| Current Liabilities | $16.8M | +18.8% |
| Total Liabilities | $16.8M | +15.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$33.1M | +60.5% |
| Capital Expenditures | $839K | +0.0% |
| Investing Cash Flow | $55.4M | +15.0% |
| Financing Cash Flow | -$45.0M | -190.8% |
| Free Cash Flow | -$33.9M | +59.9% |
| Stockholders' Equity |
| -$21.7M |
| -152.8% |